caffeic acid phenethyl ester has been researched along with clonidine in 2 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (clonidine) | Trials (clonidine) | Recent Studies (post-2010) (clonidine) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 13,692 | 2,044 | 1,394 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | clonidine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.101 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0353 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0115 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 5.365 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0173 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0173 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0173 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.21 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 5.365 | |
| Alpha-2A adrenergic receptor | Bos taurus (cattle) | 0.002 | |
| Nischarin | Rattus norvegicus (Norway rat) | 0.3662 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Liu, J; Ma, X; Ma, Z; Ning, X; Tian, C; Wang, X; Zhang, Z; Zhu, R | 1 |
| Cheng, C; Du, Y; Guo, Y; Liu, J; Ma, X; Ma, Z; Ning, X; Shi, X; Tian, C; Wang, X; Zhang, Z; Zhu, R | 1 |
2 other study(ies) available for caffeic acid phenethyl ester and clonidine
| Article | Year |
|---|---|
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
Topics: Animals; Blood-Brain Barrier; Caffeic Acids; Cell Line, Tumor; Drug Design; Free Radical Scavengers; Mice; Microglia; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Rats; Stereoisomerism; Sulfonamides | 2013 |
Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents.
Topics: Animals; Blood-Brain Barrier; Drug Design; Free Radical Scavengers; Humans; Neuroprotective Agents; Nitric Oxide; Oxidopamine; PC12 Cells; Rats; Sulfones; Sulfoxides | 2014 |